Tick-borne illnesses such as Lyme disease, babesiosis, and bartonellosis are notoriously difficult to diagnose. Symptoms overlap with dozens of other conditions, and many patients spend months, or even years, searching for answers before they find a lab equipped to look for direct evidence of infection. This is where tick-borne disease testing tlab has become a trusted resource for physicians and patients who need more clarity than a standard panel can offer.
TLab is a CAP-accredited, CLIA-certified translational diagnostics laboratory built specifically to close the gap between everyday clinical need and advanced molecular science. Rather than relying only on indirect antibody markers, tlab tick borne disease testing is designed to directly visualize metabolically active pathogens in a patient’s own blood sample. In this guide, we’ll walk through why conventional testing often falls short, how TLab’s molecular imaging technology works, and how TLab functional medicine testing fits into a root-cause approach to patient care.
Why Tick-Borne Disease Testing Is So Challenging
The Limitations of Conventional Testing
Standard tick-borne disease testing typically looks for antibodies, the immune system’s reaction to an infection, rather than the pathogen itself. Antibody levels can remain low, delayed, or inconsistent, especially in chronic or persistent infections. This is one of the main reasons conventional screening can miss active cases of Lyme disease, babesiosis, and bartonellosis, leaving both patients and physicians without a clear next step.
Why Early and Accurate Detection Matters
Because tick-borne infections can affect multiple organ systems and often coexist with inflammatory symptoms, an accurate result early in the diagnostic process can meaningfully shape a patient’s care plan. This is a central reason clinicians turn to tick-borne disease testing tlab: it is built around direct, visual evidence rather than indirect inference.
How TLab Approaches Tick-Borne Disease Testing
RNA-Based Molecular Imaging
TLab uses high-resolution molecular imaging combined with RNA-based detection methods. Instead of measuring an immune reaction, these assays are designed to directly detect the RNA of the microbe being tested for, in either blood or skin specimens.
Direct Detection of Active Pathogens
Because the test targets RNA rather than DNA or antibodies, a positive result is intended to reflect a metabolically active organism, rather than a past exposure. This distinction is a key part of why tlab tick borne disease testing is used to complement, rather than replace, a physician’s broader clinical workup. Inside TLab’s Molecular FISH Imaging
What Is In Situ Hybridization?
TLab’s molecular FISH (fluorescence in situ hybridization) imaging uses RNA probes that bind to a specific nucleic acid sequence unique to the microbe being tested. When the probe matches its target sequence, it provides direct visual evidence of the organism’s presence.
Confocal Laser Microscopy
These RNA probes are paired with confocal laser microscopy, a high-resolution imaging technique that allows TLab’s scientists to visualize the labelled pathogen within blood or skin specimens with a high degree of clarity.
TLab’s Core Tick-Borne Disease Panel
TLab’s molecular imaging panel currently includes RNA FISH probes for Bartonella (23s rRNA), Babesia (18s rRNA), and two Borrelia (Lyme) probes, one for OspA mRNA (31 kDa band) and one for 23s rRNA, with plans to expand this imaging approach to additional specimen types such as blood biofilms and skin biopsies.
High-Resolution Blood Imaging at TLab
Biofilms and Neutrophil Lysis
Alongside its RNA-based probes, TLab offers a high-resolution blood imaging test using differential staining and bright-field microscopy. This test is designed to reveal fine details such as biofilms, neutrophil lysis, and red blood cell inclusions.
What the Report Includes
Reports from this test include sample images, giving the ordering clinician visual detail that can support a differential diagnosis alongside other clinical findings. Because RNA degrades quickly once an organism is no longer metabolically active, a positive RNA-based result is intended to reflect current, active infection rather than a historical exposure, an important distinction for clinicians managing patients with persistent or relapsing symptoms.
TLab Functional Medicine: Root-Cause Testing for Tick-Borne Disease
Moving Beyond Symptom Management
Functional medicine is built on a simple idea: treat the underlying cause of a condition, not just the symptoms it produces. For practitioners working with patients who have chronic, hard-to-explain inflammatory symptoms, tlab functional medicine testing has become a useful tool for identifying whether a persistent tick-borne infection could be part of the underlying picture.
Nerve Injury Imaging for Unexplained Neuropathy
For patients with neuropathy symptoms that haven’t been explained by standard studies such as EMG or NCV, TLab also offers a confocal microscopy test that looks for nerve demyelination injury from a skin biopsy specimen, which can support treatment decision-making in complex, functional medicine cases.
Why Choose TLab for Tick-Borne Disease Testing
CAP Accreditation and CLIA Certification
TLab is accredited by the College of American Pathologists (CAP) and certified under CLIA as a high-complexity testing laboratory, reflecting rigorous, ongoing quality standards.
Years of Research Experience
Operating since 2013, TLab has served thousands of patients and works with clinicians worldwide, maintaining a CDC import permit for international specimens and a continuous feedback loop between clinical application and laboratory innovation.
Getting Started with TLab
If you are a physician or healthcare provider, TLab can set up an account, provide test requisition forms, and enable secure results reporting through its portal. If you are a patient, the first step is a conversation with your physician about whether tick borne disease testing from TLab, or TLab functional medicine testing more broadly, is appropriate for your situation.